Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06067126 · ClinicalTrials.gov registry record
Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention
A clinical trial of Overweight and Obese, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 154
- Enrollment target
- 1
- Study location
NCT06067126 is a study of Overweight and Obese that has completed, run by Kaiser Permanente. The registered enrollment target is 154 participants, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06067126, a study of Overweight and Obese, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of PrepareD is to examine whether the prepregnancy weight-loss intervention administered during the Prepare trial \[NCT02346162\] has an influence in the postnatal period. PrepareD is a cohort study (no intervention) that will address new specific aims through one in-person visit with mothers and children, dietary recalls, actigraphy, and the use of medical record weights. The goal is to collect data when the child is 3 years old. However, due to the COVID-19 pandemic, the investigators expanded the data collection window in order to collect data up to when the child is 5 years old. The investigators hypothesize that intervening on women before pregnancy is the key to breaking the multigenerational cycle of obesity.
Conditions Studied
Study Locations (1)
Oregon
- Kaiser Permanente Center for Health Research - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2024-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06067126
The ClinicalTrials.gov registry entry for NCT06067126 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,322-participant average among 197 other Overweight trials with a reported enrollment target (88% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Overweight appearing as the primary indexed condition, and to 0 interventions.
NCT06067126 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06067126 about?
NCT06067126 is a clinical study titled "Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention". The goal of PrepareD is to examine whether the prepregnancy weight-loss intervention administered during the Prepare trial \[NCT02346162\] has an influence in the postnatal period. PrepareD is a cohort study (no intervention) that will address new specific aims through one in-person visit with mothe...
What is the current status of trial NCT06067126?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2019-04-03. Estimated completion is 2024-03-12.
What conditions does trial NCT06067126 study?
This clinical trial studies the following conditions: Overweight, Obese, Postpartum, Metabolic Disorders.
Who is sponsoring clinical trial NCT06067126?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06067126 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.